NASDAQ: IMMX
IMMIX Biopharma Inc Stock Ownership - Who owns IMMIX Biopharma?

Insider buying vs selling

Have IMMIX Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jason HsuDirector2024-12-2340,000$2.19
$87.68kBuy
Jason HsuDirector2024-12-207,700$2.17
$16.68kBuy
Jason HsuDirector2024-08-228,100$2.25
$18.23kBuy
Jason HsuDirector2024-08-2115,000$2.23
$33.39kBuy
Carey NgDirector2024-08-1610,000$1.86
$18.60kBuy
Jason HsuDirector2024-07-246,000$2.15
$12.88kBuy
Jason HsuDirector2024-07-183,200$2.08
$6.64kBuy
Ilya M. RachmanCEO and Chairman2024-06-072,600$2.13
$5.54kBuy
Gabriel S. MorrisCFO2024-06-072,500$2.12
$5.30kBuy
Gabriel S. MorrisCFO2024-06-043,300$1.81
$5.97kBuy

1 of 2

IMMX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IMMX insiders and whales buy or sell their stock.

IMMX Shareholders

What type of owners hold IMMIX Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Yekaterina Chudnovsky11.78%3,241,076$6.38MInsider
Ilya M. Rachman4.13%1,136,259$2.24MInsider
Aigh Capital Management LLC4.08%1,123,663$2.21MInstitution
Carey Ng3.80%1,045,221$2.06MInsider
Jason Hsu3.43%943,000$1.86MInsider
Vladimir P. Torchilin3.29%905,200$1.78MInsider
Sean Senn3.27%899,800$1.77MInsider
Bleichroeder LP3.09%850,000$1.67MInstitution
Cable Car Capital LLC2.89%796,100$1.57MInstitution
Vanguard Group Inc2.54%698,537$1.38MInstitution

1 of 3

IMMX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMMX14.89%31.86%Net BuyingNet Buying
GBIO64.16%35.84%Net BuyingNet Buying
LTRN12.39%65.02%Net Selling
BOLD58.83%23.91%Net Buying
RPTX58.25%41.75%Net Selling

IMMIX Biopharma Stock Ownership FAQ

Who owns IMMIX Biopharma?

IMMIX Biopharma (NASDAQ: IMMX) is owned by 14.89% institutional shareholders, 31.86% IMMIX Biopharma insiders, and 53.25% retail investors. Yekaterina Chudnovsky is the largest individual IMMIX Biopharma shareholder, owning 3.24M shares representing 11.78% of the company. Yekaterina Chudnovsky's IMMIX Biopharma shares are currently valued at $6.55M.

If you're new to stock investing, here's how to buy IMMIX Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.